CoChat

Incidence and Risk of Glucocorticoid‐Associated Adverse Effects in Patients With Rheumatoid Arthritis

Wilson, Jessica C., Sarsour, Khaled, Gale, Sara, Pethö‐Schramm, Attila, Jick, Susan S., Meier, Christoph R. · 2019 · Arthritis Care & Research
Cited by 111

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Objective: Using the UK Clinical Practice Research Datalink, we examined the incidence of glucocorticoid (GC)‐related serious adverse events (SAE s) in rheumatoid arthritis (RA) and non‐RA patients and quantified the risk of SAE s in patients with RA. Methods: We matched incident patients with RA to an age‐ and sex‐matched, non‐RA comparison group of equal size. In a cohort analysis, we estimated incidence rates (IR s) and IR ratios (IRR s) for GC‐related AE s (i.e., diabetes mellitus [DM], osteoporosis, fractures, glaucoma, hypertension, gastrointestinal [GI] perforation or bleeding, thrombotic stroke or myocardial infarction [MI], or death), stratified by GC use. We conducted a series of nested case–control analyses among patients with RA, evaluating the effects of increasing cumulative and average daily GC dose. Cases of each outcome were matched to controls for age, sex, and general practice. We calculated adjusted odds ratios (OR s) with 95% confidence intervals (95% CI s) for each outcome. Results: Patients with RA had a higher incidence for all investigated SAE s except glaucoma, compared to non‐RA patients. IRR s were greater in those patients prescribed a GC than in those without. In patients with RA, GC s were associated with an elevated risk of DM (adjusted OR 1.33 [95% CI 1.14–1.56]), osteoporosis (adjusted OR 1.41 [95% CI 1.25–1.59]), thrombotic stroke or MI (adjusted OR 1.28 [95% CI 1.07–1.52]), serious infection (adjusted OR 1.28 [95% CI 1.11–1.48]), and death (adjusted OR 1.33 [95% CI 1.19–1.48]). There was a trend of increasing risk with increasing cumulative and average daily GC dose for all outcomes other than glaucoma, hypertension, and GI perforations or bleeding (P < 0.05). Conclusion: Patients with RA had an increased incidence of GC‐related AE s. Increasing cumulative and average daily GC doses were found to be associated with an increasing risk of developing an AE.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/acr.23611

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 111

Metadata

Authors
Wilson, J. C., Sarsour, K., Gale, S., Pethö‐Schramm, A., Jick, S. S., & Meier, C. R.
Venue
Arthritis Care & Research
Publisher
Wiley
Published
2019-03-28
Volume
71
Issue
4
Pages
498-511
ISSN
  • 0893-7524 (ISSN-L)
  • 2151-464X
  • 2151-4658
OpenAlex
W2805740714
Cited by
111
References
6
FWCI
8.07
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.